参考文献:1.Ellegood J, Crawley JN. Behavioral and neuroanatomical phenotypes in mouse models of autism. Neurotherapeutics 2015. 2.Acab A, Muotri AR. The use of induced pluripotent stem cell technology to advance autism research and treatment. Neurotherapeutics 2015. 3.Levin AR, Nelson CA. Inhibition-based biomarkers for autism spectrum disorder. Neurotherapeutics 2015. 4.Gamsiz ED, Sciarra LN, Maguire AM, Pescosolido MF, van Dyck L, Morrow EM. Discovery of rare mutations in autism: elucidating neurodevelopmental mechanisms. Neurotherapeutics 2015. 5.Davis PE, Peters JM, Krueger DA, Sahin M. Tuberous sclerosis: a new frontier in targeted treatment of autism. Neurotherapeutics 2015. 6.Gross C, Hoffmann A, Bassell GJ, Berry-Kravis EM. Therapeutic strategies in fragile X syndrome: from bench to bedside and back. Neurotherapeutics 2015. 7.Tilot AK, Frazier TW, II, Eng C. Balancing proliferation and connectivity in PTEN-associated autism spectrum disorder. Neurotherapeutics 2015. 8.Costales JL, Kolevzon A. Phelan鈥揗cDermid syndrome and SHANK3: implications for treatment. Neurotherapeutics 2015. 9.Pozzo-Miller L, Pati S, Percy AK. Rett syndrome: reaching for clinical trials. Neurotherapeutics 2015. 10.Margolis SS, Sell GL, Zbinden MA, Bird LM. Angelman syndrome. Neurotherapeutics 2015.
作者单位:Jeffrey L. Neul (1) Mustafa Sahin (2)
1. Division of Child Neurology, Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA 2. Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children鈥檚 Hospital, Harvard Medical School, Boston, MA, USA